Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis

Autoimmunity

Volumn 45, Issue 8, 2012, Pages 584-587

  Maugeri, Norma ^a   Franchini, Stefano ^a   Campana, Lara ^a   Baldini, Mattia ^a   Ramirez, Giuseppe A ^a   Sabbadini, Maria Grazia ^a   Rovere Querini, Patrizia ^a   Manfredi, Angelo A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

HMGB1; Innate immunity; Platelets; Systemic sclerosis; Vessel inflammation

Indexed keywords

FIBRINOGEN; HIGH MOBILITY GROUP B1 PROTEIN; PADGEM PROTEIN; THROMBOPLASTIN;

ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DEGRANULATION; HUMAN; HUMAN CELL; PLATELET MICROPARTICLE; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SYSTEMIC SCLEROSIS; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; FIBRINOGEN; HMGB1 PROTEIN; HUMANS; INFLAMMATION; P-SELECTIN; PLATELET ACTIVATION; PROTEIN TRANSPORT; SCLERODERMA, SYSTEMIC; THROMBOPLASTIN;

EID: 84867934811     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.719946     Document Type: Article

References (22)

1. Guiducci, S, O. Distler, J. H. Distler, and M. Matucci-Cerinic. 2008. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology (Oxford) 47(Suppl 5): v18-v20.
2. Pattanaik, D, M. Brown, and A. E. Postlethwaite. 2012. Vascular involvement in systemic sclerosis (scleroderma). J. Inflamm. Res 4: 105-125.
3. Gabrielli, A., E. V. Avvedimento, and T. Krieg. 2009. Scleroderma. N. Engl. J. Med 360: 1989-2003.
4. Ho-Tin-Noe, B., M. Demers, and D. D. Wagner. 2011. How platelets safeguard vascular integrity. J. Thromb. Haemost 9(Suppl 1): 56-65.
5. Postlethwaite, A. E., and T. M. Chiang. 2007. Platelet contributions to the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol 19: 574-579. (Pubitemid 47530878)
6. Maugeri, N., M. Baldini, P. Rovere-Querini, A. Maseri, M. G. Sabbadini, and A. A. Manfredi. 2009. Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity 42: 386-388.
7. Maugeri, N., P. Rovere-Querini, V. Evangelista, C. Covino, A. Capobianco, M. T. Bertilaccio, A. Piccoli, L. Totani, D. Cianflone, A. Maseri, and A. A. Manfredi. 2009. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrindependent cell clearance program. Blood 113: 5254-5265.
8. Semple, J. W., J. E. Italiano, Jr, and J. Freedman. 2011. Platelets and the immune continuum. Nat. Rev. Immunol 11: 264-274.
9. Maugeri, N., S. Malato, E. A. Femia, M. Pugliano, L. Campana, F. Lunghi, P. Rovere-Querini, F. Lussana, G. Podda, M. Cattaneo, F. Ciceri, and A. A. Manfredi. 2011. Clearance of circulating activated platelets in Polycythemia vera and essential thrombocythemia. Blood 118: 3359-3366.
10. Maugeri, N., M. Baldini, G. A. Ramirez, P. Rovere-Querini, and A. A. Manfredi. 2012. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb. Res 129: 267-273.
11. Rovere-Querini, P., M. T. Castiglioni, M. G. Sabbadini, and A. A. Manfredi. 2007. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 40: 290-294. (Pubitemid 46845523)
12. Cerinic, M. M., G. Valentini, G. G. Sorano, S. D'Angelo, G. Cuomo, L. Fenu, S. Generini, S. Cinotti, M. Morfini, A. Pignone, S. Guiducci, A. Del Rosso, R. Kalfin, D. Das, and F. Marongiu. 2003. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin. Arthritis Rheum 32: 285-295. (Pubitemid 36459278)
13. Rouhiainen, A., S. Imai, H. Rauvala, and J. Parkkinen. 2000. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost 84: 1087-1094. (Pubitemid 32014046)
14. Gauley, J., and D. S. Pisetsky. 2009. The translocation of HMGB1 during cell activation and cell death. Autoimmunity 42: 299-301.
15. Gaipl, U. S. 2009. Waste: An important immune modulator. Autoimmunity 42: 250.
16. Raucci, A., R. Palumbo, and M. E. Bianchi. 2007. HMGB1: A signal of necrosis. Autoimmunity 40: 285-289. (Pubitemid 46845522)
17. Hayakawa, K., L. D. Pham, Z. S. Katusic, K. Arai, and E. H. Lo. 2012. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery, Proc Natl Acad Sci USA 7505-7510.
18. LeRoy, E. C., C. Black, R. Fleischmajer, S. Jablonska, T. Krieg, T. A. Medsger, Jr, N. Rowell, and F. Wollheim. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol 15: 202-205. (Pubitemid 18073738)
19. LeRoy, E. C., and T. A. Medsger, Jr. 2001. Criteria for the classification of early systemic sclerosis. J. Rheumatol 28: 1573-1576.
20. Guiducci, S., J. H. Distler, A. Jungel, D. Huscher, L. C. Huber, B. A. Michel, R. E. Gay, D. S. Pisetsky, S. Gay, M. Matucci-Cerinic, and O. Distler. 2008. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 58: 2845-2853.
21. Rauch, U., D. Bonderman, B. Bohrmann, J. J. Badimon, J. Himber, M. A. Riederer, and Y. Nemerson. 2000. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96: 170-175. (Pubitemid 30456467)
22. Pendergrass, S. A., E. Hayes, G. Farina, R. Lemaire, H.W. Farber, M. L. Whitfield, and R. Lafyatis. 2010. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 5: e12106.